📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Immune checkpoint blockade lowers the threshold of naïve T-cell priming to drug-associated antigens in a dose-dependent fashion (2024)

First Author: Grice S

Attributed to: A personalised approach to manage adverse reactions to CFTR modulator therapy in patients with cystic fibrosis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/toxsci/kfae118

PubMed Identifier: 39289883

Publication URI: http://europepmc.org/abstract/MED/39289883

Type: Journal Article/Review

Parent Publication: Toxicological Sciences

Issue: 1

ISSN: 1096-0929